ERBB2 and breast cancer: In 17q23-amplified breast cancer, the RNA-binding protein DDX5 interacts with the Drosha complex and affects the maturation of miR-21, which directly inhibits PTEN, an important mechanism for trastuzumab resistance in HER2+ breast cancers 165.